Abstract:In recent years,pulmonary morphine delivery has been regarded as a novel method of administration to treat severe acute or chronic pain without inducing side effects that might be encountered if given by traditional ways.But reported pulmonary delivery equipments were open systems,which may lead to nebulized morphine leakage and absorption by upper respiratory tract.We carried out this study to investigate the pharmacokinetics of single-dose nebulized versus intravenous morphine in dogs undergoing mechanical ventilation.Six healthy dogs were assigned to two groups(n=3 in each group) randomly.After tracheal intubation and mechanical ventilation the subjects received single dose 0.66 mg/kg morphine within 10 minutes during intravenous anaesthesia either by inhalation with the ultrasonic nebulizer placed between the tracheal tube and the respirator or by intravenous injection.After a one-week washout period,a crossover was made.Arterial blood samples of 1 mL were performed every minute during administration and at 2,5,7,10,15,20,45,60,90,120,150,180,240 and 360 min following administration for determination of morphine concentration by RP-HPLC.The pharmacokinetic analyses were performed by Drug and Statistics Ver1.0 using mixed-effect models.AUC,Tmax,Cmax,and MRT(0-t) were obtained by statistical moment analysis.Otherwise,T1/2 and CL were obtained according to compartment model analysis.The main pharmacokinetic parameters of morphine after a single dose inhalation and intravenous infusion were as follows: MRT(59±14)min and(19±4)min,T1/2(21.9±5.1)min and(3.3±1.0)min,Tmax(23.0±2.7)min and(8.8±2.4)min,Cmax(0.245±0.09)mg/L and(1.09±0.32)mg/L,AUC0-∞(9.7±1.1)mg·min/L and(15.2±7.2)mg·min/L,CL(0.069±0.019)L/(min·kg) and(0.063±0.028)L/(min·kg) respectively and the absolute bioavailability of nebulized morphine 71%±20%.There was a rapid appearance of morphine in plasma after nebulized morphine.There were no significant differences(P<0.05) between nebulized and intravenous morphine in AUC and CL.As expected,T1/2 and MRT of inhaled morphine were significantly greater than those of intravenous morphine. Nebulized morphine administered by inhalational route can be rapidly and completely absorbed in dogs during mechanical ventilation without leakage or absorption by upper respiratory tract.And it had a sustained release profile,prolonged duration,and high bioavailability.

Development of nebulized morphine

Phamacokinetics of nebulized versus intravenous morphine in dogs

The pharmacokinetics of inhaled morphine delivered by an ultrasonic nebulizer in ventilated dogs.

Nebulized inhalation drug delivery: clinical applications and advancements in research

Inhaled drug delivery: Past, present, and future

Morphinan Evolution: The Impact of Advances in Biochemistry and Molecular Biology

Progress of Remifentanil Used in Obstetric Anesthesia and Analgesia

Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives As Μ/κ Opioid Receptor Dual Selective Ligands.

Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review

Recent Advancement in Inhaled Nano-drug Delivery for Pulmonary, Nasal, and Nose-to-brain Diseases

Low dose of morphine to relieve dyspnea in acute respiratory failure: the OpiDys double-blind randomized controlled trial

Transdermal and transmucosal administration of pain-relieving and anxiolytic drugs: a primer for the critical care practitioner

Morphine versus methylprednisolone or aminophylline for relieving dyspnea in patients with advanced cancer in China: a retrospective study

Nanocrystals based pulmonary inhalation delivery system: advance and challenge

Morphine Nebulized by Supersound Atomizer for Postoperative Pain Relieve in Gynaecologic and Obstetric Patients

Advances in attenuating opioid-induced respiratory depression: A narrative review

Effects of morphine, methylprednisolone and aminophylline on management of dyspnea in patients with advanced cancer

Morphine Use in the Treatment of Acute Cardiogenic Pulmonary Edema and Its Effects on Patient Outcome: A Systematic Review

Promising biomedical subcutaneous delivery system in opioid disaccustom process: In vitro/in vivo evaluation of naloxone microparticles on antagonist effect of morphine

Nebulized Therapies in COPD: Past, Present, and the Future

Cannabinoid Delivery Systems for Pain and Inflammation Treatment